Boulder, CO – December 10th, 2024 – Ambrosia Biosciences Inc. (“Ambrosia”), today announced the successful second closing of its Series A financing. This closing was led by Merck, known as MSD outside the United States and Canada, with additional participation from existing investors BVF Partners and Boulder Ventures. This additional capital brings Ambrosia’s total Series A financing to $25MM.
Read MoreSAN JOSE, CA, USA, December 10, 2024 /EINPresswire.com/ — PeopleReign, the industry-leading SaaS platform that automates IT and HR employee service, today announced 600% year over year annually recurring revenue (ARR) growth thanks to increasing adoption of its System of Intelligence AI platform that gives every employee back four to six hours of productive time per week.
Read MoreArmando Menocal, a Cuban-American civil rights lawyer and passionate climber who played a pivotal role in securing and preserving climbing access across the United States and Latin America, passed away on October 20, 2024, after a battle with lung cancer. He was 83.
A tireless advocate for climbers, he dedicated decades of his life to ensuring the sport remained accessible and minimally regulated. He is survived by his wife, Laura Rodriguez; his three sons, Matt, Diego, and Luis Manuel; his grandchildren, Alejandro, Ariel, Sierra, Wyatt, and Amelia; and his beloved dog, Wasabi. His son Marshall predeceased him in 2023.
Read MoreOnKure Therapeutics, Inc. (Nasdaq: OKUR) (“OnKure”), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines in oncology, today announced the completion of its previously announced merger of OnKure, Inc. and Reneo Pharmaceuticals, Inc. (“Reneo”). The combined company will operate under the name OnKure Therapeutics, Inc., and its shares are expected to begin trading on the Nasdaq Global Market on October 7, 2024 under the ticker symbol “OKUR”.
Read MoreST. LOUIS, Aug. 21, 2024 /PRNewswire/ — Emerson (NYSE: EMR) today announced it has made a strategic investment through its corporate venture capital arm Emerson Ventures in Symmera, an early-stage company simplifying device authentication and data protection. Boulder Ventures will co-invest with Emerson.
Read MoreBoulder, CO – August 20, 2024 – Ambrosia Biosciences Inc. (“Ambrosia” or “the Company”), today announced the successful first closing of its Series A financing. The financing totaled $16 Million and was led by BVF Partners and Boulder Ventures. Ambrosia’s financing will be used to scale up its drug discovery programs and laboratory operations in Boulder, CO.
Read MoreFor Joel Holland, what started as an impulsive decision with his wife to travel the United States in an RV has grown into a business and network that supports over 5,500 small businesses across the country, including a few right in Eagle County.
Read MoreLâle White, CEO of XiFin, wins “CEO of the Year” by San Diego Business Journal for her transformative leadership and significant contributions to the healthcare industry.
Read More
